AlphaCrest Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-161,118
Closed -$1.87M 563
2022
Q3
$1.87M Buy
+161,118
New +$2.21M 0.11% 258
2021
Q2
Sell
-16,127
Closed -$193K 1286
2021
Q1
$193K Buy
+16,127
New +$195K 0.01% 1149
2020
Q4
Sell
-31,989
Closed -$334K 1194
2020
Q3
$334K Buy
31,989
+14,489
+83% +$184K 0.04% 808
2020
Q2
$245K Buy
+17,500
New +$238K 0.04% 731
2019
Q4
Sell
-74,700
Closed -$787K 1304
2019
Q3
$787K Buy
74,700
+38,000
+104% +$454K 0.05% 698
2019
Q2
$534K Sell
36,700
-11,100
-23% -$157K 0.05% 674
2019
Q1
$671K Buy
47,800
+5,700
+14% +$92.3K 0.1% 339
2018
Q4
$735K Buy
+42,100
New +$684K 0.22% 125

Other funds holding INVA

AlphaCrest Capital Management's INVA Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Innoviva (INVA) in Q4 2022, closing a stake of 161,118 shares — an estimated $1.87M sold.

AlphaCrest Capital Management first reported a position in INVA in Q4 2018 and held it in 8 quarters. The position peaked at $1.87M in Q3 2022. 209 funds tracked by Wall St. Rank hold INVA as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Innoviva position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 161,118 Innoviva shares in Q4 2022, an estimated $1.87M.
  • AlphaCrest Capital Management first reported a position in Innoviva in Q4 2018 and held it in 8 quarters.
  • AlphaCrest Capital Management's Innoviva position peaked at $1.87M in Q3 2022.
  • 209 funds tracked by Wall St. Rank held Innoviva as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.